On April 25, Zhejiang Pharmaceutical released the first quarter report. In the first quarter of this year, revenues were 1,922,400,190.61 yuan, up 61.68% from last year's 1,189,011,872.41 yuan. The net profit attributable to shareholders of listed companies was 465,340,324.88 yuan, up 1,838.06% from 24,010,668.25 yuan in the same period last year. Zhejiang Medical Major Events Notice: 1. In January 2018, the company received a final judgment from the Houston District Court in the United States, ruling that Zhejiang Pharmaceutical did not infringe Kaneka's Coenzyme Q10 patent. The company's coenzyme Q10 product related matters were closed in the US lawsuit. 2. The coenzyme Q10 produced by the company's Xinchang Pharmaceutical Factory, due to the implementation of the new production process, needs to upgrade the production facilities. It is decided to suspend production from April 2018, and the production stoppage is expected to be 3-6 months. The suspension of this coenzyme Q10 will not have a major impact on the company's operations and financial status.
Protein: The protein based on a certain indicator negative charge attracts protein cationic, ionizing causes the color change.
Q1. Do you offer customer brand ? A: We have been doing OEM and ODM service for more than 16 years.
Protection of your sales area, ideas of design and all your private
information.
Q2. What certificate do you have ? A: CE, ISO 9001, ISO13485 certificates
Q3. How is your quality? A: Good comments from all over the world, 100% QC testing before delivery.
Q4. Is it OK to print my logo on product? A: Yes. You can make your own design.
Q5: Do you offer samples for the products? A: Yes, we offer samples free charge, but customer need to bear the delivery fee.
Urine Ph Strips,Urine Test Strips Protein,Diastix Reagent Strips For Urinalysis,Electronic Ph Tester For Urine And Saliva Changchun LYZ Technology Co., Ltd , https://www.lyzinstruments.com
Zhejiang Pharmaceutical: First-quarter net profit increased by 1838%